Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of Octoberand that an FDA application could soon follow. But more than 60 researchers …
Read More
Categories
Pfizer urged to hold off on coronavirus vaccine until late November: report
Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of Octoberand that an FDA application could soon follow. But more than 60 researchers …
